Investor News Fresenius Medical Care AG & Co. KGaA Investor Relations Else-Kr ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: ir@fmc-ag.com North America: Te

Fresenius Medical Care

for the Fiscal Year 2008

Bad Homburg, Germany Fresenius Medical Care AG & Co. KGaA

( the Company ), the world s largest provider of Dialysis Services and

Products, today announced that it has filed the annual report 2008 under Form

20-F with the U.S. Securities and Exchange Commission (SEC).

report is available at

the Company s website in the Investor Relations section:

http://www.fmc-ag.com/internet/fmc/fmcag/neu/fmcpub.nsf/Content/Publications_2008,

as well as at the SEC s website, www.sec.gov.

A hard copy of Fresenius Medical Care s annual report on Form 20-F

including the complete audited financial statements may be obtained from the

Company free of charge upon request to the Company s Investor

Relations department by email at ir@fmc-ag.com

Medical Care is the world s largest integrated provider of products and

services for individuals undergoing dialysis because of chronic kidney failure,

a condition that affects more than 1,770,000 individuals worldwide. Through its

network of 2,388 dialysis clinics in North America, Europe, Latin America,

Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to

184,086 patients around the globe. Fresenius Medical Care is also the world s

leading provider of dialysis products such as hemodialysis machines, dialyzers

and related disposable products. Fresenius Medical Care is listed on the

Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS,

more information about Fresenius Medical Care visit the Company s website at

release contains forward-looking statements that are subject to various risks

and uncertainties. Actual results could differ materially from those described

in these forward-looking statements due to certain factors, including changes

in business, economic and competitive conditions, regulatory reforms, foreign

exchange rate fluctuations, uncertainties in litigation or investigative

proceedings, and the availability of financing. These and other risks and

uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA s

reports filed with the U.S. Securities and Exchange Commission. Fresenius

Medical Care AG & Co. KGaA does not undertake any responsibility to update

the forward-looking statements in this release.